Wang Q F, Farnworth P G, Findlay J K, Burger H G
Prince Henry's Institute of Medical Research, South Melbourne, Victoria, Australia.
Endocrinology. 1990 Sep;127(3):1385-93. doi: 10.1210/endo-127-3-1385.
The effects of bovine FSH-suppressing protein (FSP) or follistatin on activin- and GnRH-stimulated FSH synthesis and secretion have been studied using cultured pituitary cells from adult male Sprague-Dawley rats. Exposure to FSP (0.001-10 nM) for 3 days dose-dependently suppressed basal FSH secretion (IC50 = 146 +/- 21 pM., mean +/- SE), cellular content (IC50 = 269 +/- 8 pM) and total FSH (IC50 = 181 +/- 25 pM), with no effect on LH. Activin (0.3 nM) increased FSH secretion 2.1-fold, cellular content 1.3-fold, and total FSH 1.9-fold during a 3-day incubation, but these increases were dose-dependently inhibited by concomitant treatment with 35-kDa bovine FSP (0.1-3 nM), with complete inhibition occurring at concentrations between 1 and 3 nM. The 31- and 39-kDa forms of bovine FSP also antagonized the actions of activin. GnRH (1 nM) increased FSH secretion 1.8-fold and total FSH 1.6-fold during a 3-day incubation, effects that were dose-dependently inhibited by concomitant treatment with 35-kDa bovine FSP. The highest tested concentration of FSP (3 nM) suppressed GnRH-stimulated FSH secretion and total FSH to 59 and 57%, respectively, of the levels found in untreated cultures. All three forms of bovine FSP produced a significant inhibition of FSH secretion and total FSH stimulated by GnRH. FSP also suppressed FSH secretion and total FSH in response to activators of protein kinase C including 100 nM phorbol 12-myristate 13-acetate (43 and 59%, respectively) and 100 nM mezerein (40 and 60%, respectively). Finally, treatment of cultured pituitary cells with 35-kDa FSP at 1 and 3 nM for 3 days resulted in 21 and 24% decreases in GnRH binding sites, respectively. It is concluded that (i) FSP inhibits not only the secretion but also the synthesis of FSH induced by activin and GnRH in long-term culture, and (ii) FSP may cause its inhibitory effects on GnRH by suppression of the protein kinase C system, and possibly by reduction of GnRH binding sites.
利用成年雄性斯普拉格 - 道利大鼠的垂体细胞培养物,研究了牛促卵泡激素抑制蛋白(FSP)或卵泡抑素对激活素和促性腺激素释放激素(GnRH)刺激的促卵泡激素(FSH)合成与分泌的影响。用FSP(0.001 - 10 nM)处理3天,剂量依赖性地抑制基础FSH分泌(IC50 = 146 ± 21 pM,平均值 ± 标准误)、细胞内含量(IC50 = 269 ± 8 pM)和总FSH(IC50 = 181 ± 25 pM),对促黄体生成素(LH)无影响。在3天的孵育过程中,激活素(0.3 nM)使FSH分泌增加2.1倍、细胞内含量增加l.3倍以及总FSH增加1.9倍,但同时用35 kDa牛FSP(0.1 - 3 nM)处理可剂量依赖性地抑制这些增加,在1至3 nM浓度时完全抑制。31 kDa和39 kDa形式的牛FSP也拮抗激活素的作用。GnRH(1 nM)在3天孵育期间使FSH分泌增加1.8倍、总FSH增加1.6倍,同时用35 kDa牛FSP处理可剂量依赖性地抑制这些作用。所测试的FSP最高浓度(3 nM)将GnRH刺激的FSH分泌和总FSH分别抑制至未处理培养物中水平的59%和57%。三种形式的牛FSP均对GnRH刺激的FSH分泌和总FSH产生显著抑制。FSP还抑制对蛋白激酶C激活剂(包括100 nM佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯,分别为43%和59%;以及100 nM大戟二萜醇酯,分别为40%和60%)的反应所导致的FSH分泌和总FSH。最后,用1 nM和3 nM的35 kDa FSP处理培养的垂体细胞3天,分别使GnRH结合位点减少21%和24%。结论是:(i)FSP在长期培养中不仅抑制激活素和GnRH诱导的FSH分泌,还抑制其合成;(ii)FSP可能通过抑制蛋白激酶C系统并可能通过减少GnRH结合位点而对GnRH产生抑制作用。